Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00055393 · ClinicalTrials.gov registry record · NA
Bupropion in the Treatment of Pathological Gambling
A NA study, sponsored by University of Iowa.
- Completed
- Registry status
- NA
- Development phase
- 80
- Enrollment target
NCT00055393: Completed NA study, sponsored by University of Iowa.
NCT00055393 is a NA study that has completed, run by University of Iowa. The registered enrollment target is 80 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00055393, a NA study, has completed, sponsored by University of Iowa.
- COMPLETED
- Registry status
- NA
- Development phase
- 80 participants
- Enrollment target
Study Summary
This study will determine whether the drug bupropion is an effective treatment for Pathological Gambling.
Interventions
- DRUG Placebo
- DRUG Bupropion
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 80 participants |
| Start Date | 2002-07 |
| Est. Completion | 2006-04 |
| Phase | NA |
What the finished NCT00055393 record still lists
NCT00055393 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 80 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00055393 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00055393 about?
NCT00055393 is a clinical study titled "Bupropion in the Treatment of Pathological Gambling". This study will determine whether the drug bupropion is an effective treatment for Pathological Gambling.
What is the current status of trial NCT00055393?
This trial is currently completed. It is a NA study. The enrollment target is 80 participants. The study started on 2002-07. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00055393?
The interventions under investigation include: Placebo (DRUG), Bupropion (DRUG).
Who is sponsoring clinical trial NCT00055393?
This trial is sponsored by University of Iowa, which has 228 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00055393's enrollment target sits among peer trials
80 994th of 2000 higher than 941 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01243931 · 80 participants · NA
Optical Coherence Tomography Guided Transepithelial Phototherapeutic Keratectomy
- NCT01659203 · 80 participants · Phase 1
Proton or Photon RT for Retroperitoneal Sarcomas
- NCT01803451 · 80 participants · Early Phase 1
Glucagon-like Peptide 1, Glucose Metabolism and Gastric Bypass
- NCT01964859 · 80 participants · Phase 2
Feasibility Study for Fibroblast Autologous Skin Grafts
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia